Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A SARS-CoV-2 Delta Variant Containing Mutation in the Probe Binding Region Used for qRT-PCR Test in Japan Exhibited Atypical PCR Amplification and Might Induce False Negative Result

View ORCID ProfileSamiul Alam Rajib, Yasuhiro Ogi, View ORCID ProfileMd. Belal Hossain, View ORCID ProfileTerumasa Ikeda, Eiichi Tanaka, Tatsuya Kawaguchi, View ORCID ProfileYorifumi Satou
doi: https://doi.org/10.1101/2021.11.15.21266335
Samiul Alam Rajib
aDivision of Genomics & Transcriptomics, The Joint Research Center for Human Retrovirus Infection, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samiul Alam Rajib
Yasuhiro Ogi
bKumamoto City Medical Association Inspection Center, 2-3-40 Minami Kumamoto, Chuo-ku, Kumamoto 860-0812, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Md. Belal Hossain
aDivision of Genomics & Transcriptomics, The Joint Research Center for Human Retrovirus Infection, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Md. Belal Hossain
Terumasa Ikeda
cDivision of Molecular Virology and Genetics, The Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Terumasa Ikeda
Eiichi Tanaka
bKumamoto City Medical Association Inspection Center, 2-3-40 Minami Kumamoto, Chuo-ku, Kumamoto 860-0812, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuya Kawaguchi
bKumamoto City Medical Association Inspection Center, 2-3-40 Minami Kumamoto, Chuo-ku, Kumamoto 860-0812, Japan
dDepartment of Hematology and Infectious Diseases, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
eDepartment of Medical Technology, Kumamoto Health Science University, 325 Izumi-machi, Kita-ku, Kumamoto 861-5598, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yorifumi Satou
aDivision of Genomics & Transcriptomics, The Joint Research Center for Human Retrovirus Infection, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yorifumi Satou
  • For correspondence: y-satou@kumamoto-u.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

A recent pandemic of SARS-CoV-2 infection has caused severe health problems and substantially restricted social and economic activities. To cope with such an outbreak, the identification of infected individuals with high accuracy is vital. qRT-PCR plays a key role in the diagnosis of SARS-CoV-2 infection. The N protein-coding region is widely analyzed in qRT-PCR for the diagnosis of SARS-CoV-2 infection in Japan. We recently encountered two cases of SARS-CoV-2-positive specimens showing atypical amplification curves in the qRT-PCR. We performed whole-genome sequencing and found that the virus was a Delta-type variant of SARS-CoV-2 with a single nucleotide mutation in the probe-binding site. To evaluate the extent of spread of the variant in the area, we performed whole viral genome sequencing of samples collected from 61 patients infected with SARS-CoV-2 during the same time and in the same area. There were no other cases with the same mutation, indicating that the variant had not spread in the area. Furthermore, we performed phylogenetic analysis with various SARS-CoV-2 sequences deposited in the public database. Hundreds of variants were reported globally, and one in Japan were found to contain the same mutation. Phylogenetic analysis showed that the variant was very close to other Delta variants endemic in Japan but quite far from the variants containing the same mutation reported from outside Japan, suggesting that the variant would have been sporadically generated in some domestic areas. These findings propose two key points: i) mutations in the region used for SARS-CoV-2 qRT-PCR can cause abnormal amplification curves; therefore, the qRT-PCR result should not just be judged in an automated manner, but also manually checked by the examiner to prevent false-negative results, and ii) various mutations can be generated sporadically and unpredictably; therefore, efficient and robust screening systems are needed to promptly monitor the emergence of de novo variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by research grants from the Japan Agency for Medical Research and Development (AMED) (JP21fk0410023, JP21wm0325015, JP21jm0210074) to Y. Satou, the JSPS Leading Initiative for Excellent Young Researchers (LEADER), Japan Science and Technology Agency (JST) A-STEP (JPMJTM20SL), Shin-Nihon Foundation of Advanced Medical Research and an intramural grant from the Kumamoto University COVID-19 Research Projects (AMABIE) to T. Ikeda. The funders had no role in the study design, data collection, data interpretation, or discussion regarding submission for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Samples were collected by the Kumamoto City Medical Association Inspection Center. The downstream analyses were performed at the Division of Genomics and Transcriptomics in the Joint Research Center for Human Retrovirus Infection, Kumamoto University [Approved by the Ethics Review Committee of the Faculty of Life Sciences Kumamoto University (Approval no. 2223)].

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data availability statement

The SARS-CoV-2 genome sequences were downloaded from GISAID, which are subject to GISAID’s terms and conditions (https://www.gisaid.org/registration/terms-of-use/).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A SARS-CoV-2 Delta Variant Containing Mutation in the Probe Binding Region Used for qRT-PCR Test in Japan Exhibited Atypical PCR Amplification and Might Induce False Negative Result
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A SARS-CoV-2 Delta Variant Containing Mutation in the Probe Binding Region Used for qRT-PCR Test in Japan Exhibited Atypical PCR Amplification and Might Induce False Negative Result
Samiul Alam Rajib, Yasuhiro Ogi, Md. Belal Hossain, Terumasa Ikeda, Eiichi Tanaka, Tatsuya Kawaguchi, Yorifumi Satou
medRxiv 2021.11.15.21266335; doi: https://doi.org/10.1101/2021.11.15.21266335
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A SARS-CoV-2 Delta Variant Containing Mutation in the Probe Binding Region Used for qRT-PCR Test in Japan Exhibited Atypical PCR Amplification and Might Induce False Negative Result
Samiul Alam Rajib, Yasuhiro Ogi, Md. Belal Hossain, Terumasa Ikeda, Eiichi Tanaka, Tatsuya Kawaguchi, Yorifumi Satou
medRxiv 2021.11.15.21266335; doi: https://doi.org/10.1101/2021.11.15.21266335

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4833)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)